Viewpoints: Donald Trump On Imported Prescription Drugs; In ‘Shadow’ Of GOP Convention, Obamacare’s Impact
A selection of opinions on health care from around the country.
The independent source for health policy research, polling, and news.
36,901 - 36,920 of 112,624 Results
A selection of opinions on health care from around the country.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Outlets report on health news from Massachusetts, New York, Connecticut, Nevada, Georgia, Iowa and California.
Meanwhile, in New Hampshire, a new, 10-bed crisis unit at the state hospital is experiencing challenges and growing pains. Also, a new study details the reasons why rural hospitals struggle.
A study has found that one in 10 U.S. adults reported experiencing tinnitus, a persistent ringing, roaring or buzzing in the ears. But surprisingly few doctors are recommending behavioral therapy, which has been found to be effective. In other public health news, the first CRISPR trial with human patients may start next month, medical journals are doing little to police studies using contaminated or misidentified cells and officials warn about a potentially dangerous tick-borne disease.
Anecdotal evidence suggests that the epidemic has also hit hard in immigrant communities that are unfamiliar with both the signs of drug abuse and the labyrinth of treatment options available.
Attorney General Pam Bondi's office filed a brief with the state's Supreme Court as part of a more than year-long legal dispute over the requirement. Elsewhere, Texas Republican Gov. Greg Abbott is fundraising off rules regulating the disposal of fetal remains.
Most cases alleging a doctor's violation of patient privacy or medical information security are closed out of public view through these letters. ProPublica now posts hundreds of them in its HIPAA Helper tool. In other health IT news, a New York surgeon experiments with augmented reality to help understand the brain.
Only makers of brand-name drugs have a legal duty to update their warning labels if they learn of new risks or side effects, the Supreme Court ruled five years ago. But that leaves millions of users in an unregulated safety gap. Meanwhile, startups are in a race to develop a drug that targets the pathway that helps mellow patients out.
The quality ratings were set to be released last spring but members of Congress and the hospital industry raised questions about the criteria.
After discovering Zika in the Culex mosquito, scientists are warning that more research is needed. But if they begin detecting the virus in the species in large numbers and on a consistent basis, experts say “that would be a game changer.”
Speakers at a political meeting in Kansas and a new report in Florida urge state leaders to reconsider decisions not to expand Medicaid under the federal health law.
The company said it may also get out of the non-exchange markets too.
Theranos said the hires represent the company's latest in a series of "significant actions" to make sure its laboratories, medical products and operations meet the highest standards.
The District of Columbia and 11 states, including California, New Hampshire and Tennessee, have joined the Justice Department's lawsuit.
The department says the Aetna-Humana and Anthem-Cigna deals would lead to higher prices and reduced benefits for consumers.
Today's early morning highlights from the major news organizations.
The department says the Aetna-Humana and Anthem-Cigna mergers would lead to higher prices and reduced benefits for consumers.
A selection of opinions on health care from around the country.
Each week, KHN finds interesting reads from around the Web.
© 2026 KFF